Table 5 Cell population content (%) found in early apoptosis, late apoptosis, necrosis, and live cells caused by PSS, PL, and cisplatin exposure 4 breast cancer cell lines

MCF7

 - Untreated

87.74 ± 5.12

2.53 ± 0.81

22.41 ± 0.80

0.57 ± 0.22

 - PSS

78.72 ± 7.34

2.55 ± 0.48

31.66 ± 6.74

0.70 ± 0.35

 - PL

75.59 ± 4.70

6.52 ± 0.47 ^**

27.77 ± 5.05

0.32 ± 0.15

 - Cisplatin

54.78 ± 4.65 ^***

23.76 ± 3.76 ^***

30.56 ± 11.09

1.41 ± 0.44

T47D

 - Untreated

96.06 ± 1.81

1.39 ± 0.40

3.24 ± 1.30

0.24 ± 0.09

 - PSS

91.06 ± 0.62 ^*

1.67 ± 0.09

6.56 ± 0.52 ^*

0.71 ± 0.07 ^**

 - PL

83.57 ± 1.38 ^***

4.55 ± 0.28 ^****

11.24 ± 1.24 ^***

0.65 ± 0.04 ^**

 - Cisplatin

52.18 ± 2.88 ^****

33.26 ± 2.20 ^****

13.73 ± 0.70 ^****

0.82 ± 0.21 ^*

MDA-MB-231

 - Untreated

96.65 ± 1.34

0.93 ± 0.29

2.16 ± 0.99

0.26 ± 0.07

 - PSS

87.99 ± 1.63 ^**

1.87 ± 0.13 ^*

8.95 ± 1.19 ^**

1.19 ± 0.37 ^*

 - PL

89.21 ± 1.20 ^**

1.80 ± 0.05 ^*

7.70 ± 0.86 ^**

1.30 ± 0.47

 - Cisplatin

70.22 ± 3.49 ^****

11.87 ± 1.38 ^****

15.99 ± 2.23 ^***

1.92 ± 0.64 ^*

MDA-MB-468

 - Untreated

99.08 ± 0.11

0.56 ± 0.03

0.28 ± 0.07

0.28 ± 0.19

 - PSS

88.01 ± 1.41 ^****

3.17 ± 0.54 ^***

8.33 ± 1.23 ^****

0.24 ± 0.05

 - PL

90.11 ± 1.26 ^****

2.90 ± 0.32 ^****

6.80 ± 1.12 ^***

0.23 ± 0.04

 - Cisplatin

43.64 ± 5.69 ^****

34.81 ± 5.04 ^****

20.40 ± 1.89 ^****

1.19 ± 0.28